Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword

Published:2017-01 Issue:1 Volume:222 Page:89-100
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Dajon Marion,Iribarren Kristina,Cremer Isabelle^ORCID

Funder

“Institut National de la Santé et de la Recherche Médicale,” the “Fondation ARC pour la recherche sur le cancer,” the “Fondation de France”

Université Pierre et Marie Curie

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference151 articles.

1. Toll-like receptor agonists in cancer therapy;Adams;Immunotherapy,2009

2. Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer;Ahmed;Ann. Surg. Oncol.,2013

3. Pathogen recognition and innate immunity;Akira;Cell,2006

4. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy;Apetoh;Nat. Med.,2007

5. Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization;Aspord;J. Invest. Dermatol.,2014

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Participation of TLRs in cancer immunopathogenesis and drug resistance via interacting with immunological and/or non-immunological signaling pathways as well as lncRNAs;International Immunopharmacology;2024-10

2. Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody–Drug Conjugate Payloads;Journal of Medicinal Chemistry;2024-08-22

3. Clinical landscape of macrophage-reprogramming cancer immunotherapies;British Journal of Cancer;2024-06-03

4. Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis;PLOS ONE;2024-05-06

5. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3